These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 36353118

  • 21. N7-methylguanosine-related lncRNAs: Distinction between hot and cold tumors and construction of predictive models in colon adenocarcinoma.
    Cheng Z, Wang J, Xu Y, Jiang T, Xue Z, Li S, Zhao Y, Song H, Song J.
    Front Oncol; 2022; 12():951452. PubMed ID: 36185235
    [Abstract] [Full Text] [Related]

  • 22. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
    Liu Z, Ren C, Cai J, Yin B, Yuan J, Ding R, Ming W, Sun Y, Li Y.
    Molecules; 2023 Apr 07; 28(8):. PubMed ID: 37110517
    [Abstract] [Full Text] [Related]

  • 23. Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma.
    Zhang C, Zhou D, Wang Z, Ju Z, He J, Zhao G, Wang R.
    Front Genet; 2022 Apr 07; 13():907754. PubMed ID: 35754819
    [Abstract] [Full Text] [Related]

  • 24. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y, Zhao Q, Wu Y, Wang G, Huang Y, Sun W, Zhang M.
    Front Genet; 2022 Apr 07; 13():989719. PubMed ID: 36212154
    [Abstract] [Full Text] [Related]

  • 25. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W, Zhao F, Yu X, Guan S, Suo H, Tao Z, Qiu Y, Wu Y, Cao Y, Jin F.
    J Transl Med; 2020 Nov 23; 18(1):442. PubMed ID: 33225954
    [Abstract] [Full Text] [Related]

  • 26. N7-methylguanosine-related lncRNAs: Predicting the prognosis and diagnosis of colorectal cancer in the cold and hot tumors.
    Wu JY, Song QY, Huang CZ, Shao Y, Wang ZL, Zhang HQ, Fu Z.
    Front Genet; 2022 Nov 23; 13():952836. PubMed ID: 35937987
    [Abstract] [Full Text] [Related]

  • 27. Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer.
    Cai J, Ji Z, Wu J, Chen L, Zheng D, Chen Y, Zhang X, Xie W, Huang J, Chen M, Lin R, Lin W, Chen Y, Li Z.
    Front Genet; 2022 Nov 23; 13():949314. PubMed ID: 36092873
    [Abstract] [Full Text] [Related]

  • 28. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X, Chen C, Li X, Yang J, Zhang W, Wang X, Zhang H, Peng M, Li L, Luo P.
    Front Oncol; 2023 Nov 23; 13():972558. PubMed ID: 37064115
    [Abstract] [Full Text] [Related]

  • 29. Identification of N7-methylguanosine-related IncRNA signature as a potential predictive biomarker for colon adenocarcinoma.
    Ma X, Yang B, Yang Y, Wu G, Ma X, Yu X, Li Y, Wang Y, Guo Q.
    Front Genet; 2022 Nov 23; 13():946845. PubMed ID: 36105111
    [Abstract] [Full Text] [Related]

  • 30. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y, Luo X, Wang Q, Chen J, Zhang X, Li Y, Chen Y, Li X, Han S.
    Front Genet; 2022 Nov 23; 13():862741. PubMed ID: 35368663
    [Abstract] [Full Text] [Related]

  • 31. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
    Liu P, Dong C, Shi H, Yan Z, Zhang J, Liu J.
    J Gastrointest Oncol; 2022 Dec 23; 13(6):3169-3182. PubMed ID: 36636051
    [Abstract] [Full Text] [Related]

  • 32. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J, Wang H, Yao Y, Wu Z, Chen L, Jin C, Shi Z, Wu C, Hu X.
    Aging (Albany NY); 2022 Jun 29; 14(12):5233-5249. PubMed ID: 35771136
    [Abstract] [Full Text] [Related]

  • 33. Identification of m7G-Related LncRNA Signature for Predicting Prognosis and Evaluating Tumor Immune Infiltration in Pancreatic Adenocarcinoma.
    Lu J, Yang P, Yu L, Xie N, Wu Y, Li B.
    Diagnostics (Basel); 2023 May 11; 13(10):. PubMed ID: 37238181
    [Abstract] [Full Text] [Related]

  • 34. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L, Xiao K, Dong Z, Meng T, Cheng X, Xu Y.
    J Cancer Res Clin Oncol; 2023 Sep 11; 149(12):10543-10559. PubMed ID: 37291405
    [Abstract] [Full Text] [Related]

  • 35. A novel prognostic model based on telomere-related lncRNAs in gastric cancer.
    Ding X, Zhang Y, You S.
    Transl Cancer Res; 2024 Sep 30; 13(9):4608-4624. PubMed ID: 39430825
    [Abstract] [Full Text] [Related]

  • 36. Neutrophil extracellular traps (NETs)-related lncRNAs signature for predicting prognosis and the immune microenvironment in breast cancer.
    Jiang T, Wang Y, Chen X, Xia W, Xue S, Gu L, Guo L, Lin H.
    Front Cell Dev Biol; 2023 Sep 30; 11():1117637. PubMed ID: 36819091
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN, Ma L, Liu N.
    J Transl Med; 2018 Sep 27; 16(1):264. PubMed ID: 30261893
    [Abstract] [Full Text] [Related]

  • 40. Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.
    Li X, Li Y, Yu X, Jin F.
    J Transl Med; 2020 Aug 31; 18(1):331. PubMed ID: 32867770
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.